Effects of physiological quercetin metabolites on interleukin-1β-induced inducible NOS expression

Journal of Nutritional Biochemistry

Volumn 23, Issue 11, 2012, Pages 1394-1402

  Cho, Jae Min ^a   Chang, Seo Yoon ^a   Kim, Dong Bin ^a   Needs, Paul W ^b   Jo, Yang Hyeok ^a   Kim, Myung Jun ^a  

^a The Catholic University of Korea   (South Korea)

^b INSTITUTE OF FOOD RESEARCH   (United Kingdom)

Author keywords

INOS; Interleukin 1 ; NF B; Quercetin metabolites; RINm5F cells

Indexed keywords

ADENOSINE TRIPHOSPHATE; DNA; I KAPPA B ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; INSULIN; INTERLEUKIN 1BETA; ISORHAMNETIN 3 GLUCURONIDE; MESSENGER RNA; NITRITE; QUERCETIN; QUERCETIN 3 GLUCURONIDE; QUERCETIN 3' SULFATE; QUERCETIN DERIVATIVE; TRANSCRIPTION FACTOR RELA; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; GENE ACTIVITY; GENE EXPRESSION; INSULIN RELEASE; NONHUMAN; NUCLEOCYTOPLASMIC TRANSPORT; PANCREAS ISLET BETA CELL; PHYSIOLOGICAL PROCESS; PROMOTER REGION; PROTEIN DNA BINDING; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RAT;

ANIMALS; CELLS, CULTURED; GENE EXPRESSION REGULATION, ENZYMOLOGIC; I-KAPPA B PROTEINS; INSULIN; INTERLEUKIN-1BETA; ISLETS OF LANGERHANS; NF-KAPPA B; NITRIC OXIDE SYNTHASE TYPE II; NITRITES; PHOSPHORYLATION; PROMOTER REGIONS, GENETIC; QUERCETIN; RATS;

RATTUS;

EID: 84862521881     PISSN: 09552863     EISSN: 18734847     Source Type: Journal    
DOI: 10.1016/j.jnutbio.2011.08.007     Document Type: Article

References (52)

1. Andre I., Gonzalez A., Wang B., Katz J., Benoist C., Mathis D. Checkpoints in the progression of autoimmune disease: lessons from diabetes models. Proc Natl Acad Sci U S A 1996, 93:2260-2263.
2. Mandrup-Poulsen T. The role of interleukin-1 in the pathogenesis of IDDM. Diabetologia 1996, 39:1005-1029.
3. Southern C., Schulster D., Green I.C. Inhibition of insulin secretion by interleukin-1 beta and tumour necrosis factor-alpha via an l-arginine-dependent nitric oxide generating mechanism. FEBS Lett 1990, 276:42-44.
4. Rabinovitch A. An update on cytokines in the pathogenesis of insulin-dependent diabetes mellitus. Diabetes Metab Rev 1998, 14:129-151.
5. Salehi A., Carlberg M., Henningson R., Lundquist I. Islet constitutive nitric oxide synthase: biochemical determination and regulatory function. Am J Physiol 1996, 270:C1634-C1641.
6. Tabatabaie T., Vasquez-Weldon A., Moore D.R., Kotake Y. Free radicals and the pathogenesis of type 1 diabetes: beta-cell cytokine-mediated free radical generation via cyclooxygenase-2. Diabetes 2003, 52:1994-1999.
7. Ho E., Antioxidants B.r.a.y.T.M. NFkappaB activation, and diabetogenesis. Proc Soc Exp Biol Med 1999, 222:205-213.
8. Kutlu B., Cardozo A.K., Darville M.I., Kruhoffer M., Magnusson N., Orntoft T., et al. Discovery of gene networks regulating cytokine-induced dysfunction and apoptosis in insulin-producing INS-1 cells. Diabetes 2003, 52:2701-2719.
9. Hertog M.G., Hollman P.C., Katan M.B., Kromhout D. Intake of potentially anticarcinogenic flavonoids and their determinants in adults in the Netherlands. Nutr Cancer 1993, 20:21-29.
10. Dashwood R.H., Xu M., Hernaez J.F., Hasaniya N., Youn K., Razzuk A. Cancer chemopreventive mechanisms of tea against heterocyclic amine mutagens from cooked meat. Proc Soc Exp Biol Med 1999, 220:239-243.
11. Haqqi T.M., Anthony D.D., Gupta S., Ahmad N., Lee M.S., Kumar G.K., et al. Prevention of collagen-induced arthritis in mice by a polyphenolic fraction from green tea. Proc Natl Acad Sci U S A 1999, 96:4524-4529.
12. Coskun O., Kanter M., Korkmaz A., Oter S. Quercetin, a flavonoid antioxidant, prevents and protects streptozotocin-induced oxidative stress and beta-cell damage in rat pancreas. Pharmacol Res 2005, 51:117-123.
13. Kobori M., Masumoto S., Akimoto Y., Takahashi Y. Dietary quercetin alleviates diabetic symptoms and reduces streptozotocin-induced disturbance of hepatic gene expression in mice. Mol Nutr Food Res 2009, 53:859-868.
14. Youl E., Bardy G., Magous R., Cros G., Sejalon F., Virsolvy A., et al. Quercetin potentiates insulin secretion and protects INS-1 pancreatic beta-cells against oxidative damage via the ERK1/2 pathway. Br J Pharmacol 2010, 161:799-814.
15. Kang J.H., Chang S.Y., Jang H.J., Cho J.M., Kim D.B., Lee S.S., et al. Quercetin-induced upregulation of human GCLC gene is mediated by cis-regulatory element for early growth response protein-1 (EGR1) in INS-1 beta-cells. J Cell Biochem 2009, 108:1346-1355.
16. Manach C., Williamson G., Morand C., Scalbert A., Remesy C. Bioavailability and bioefficacy of polyphenols in humans. I. Review of 97 bioavailability studies. Am J Clin Nutr 2005, 81:230S-242S.
17. Needs P.W., Kroon A. Convenient synthesis of metabolically important quercetin glucuronides and sulfates. Tetrahedron 2006, 62:6862-6868.
18. Kim M.J., Ryu G.R., Kang J.H., Sim S.S., Min D.S., Rhie D.J., et al. Inhibitory effects of epicatechin on interleukin-1beta-induced inducible nitric oxide synthase expression in RINm5F cells and rat pancreatic islets by down-regulation of NF-kappaB activation. Biochem Pharmacol 2004, 68:1775-1785.
19. Kim M.J., Kang J.H., Park Y.G., Ryu G.R., Ko S.H., Jeong I.K., et al. Exendin-4 induction of cyclin D1 expression in INS-1 beta-cells: involvement of cAMP-responsive element. J Endocrinol 2006, 188:623-633.
20. Kang J.H., Kim M.J., Ko S.H., Jeong I.K., Koh K.H., Rhie D.J., et al. Upregulation of rat Ccnd1 gene by exendin-4 in pancreatic beta cell line INS-1: interaction of early growth response-1 with cis-regulatory element. Diabetologia 2006, 49:969-979.
21. Kim M.J., Kang J.H., Chang S.Y., Jang H.J., Ryu G.R., Ko S.H., et al. Exendin-4 induction of Egr-1 expression in INS-1 beta-cells: interaction of SRF, not YY1, with SRE site of rat Egr-1 promoter. J Cell Biochem 2008, 104:2261-2271.
22. McClenaghan N.H., Flatt P.R. Physiological and pharmacological regulation of insulin release: insights offered through exploitation of insulin-secreting cell lines. Diabetes Obes Metab 1999, 1:137-150.
23. Lang J., Boulay F., Parker P., Gierschik P., Wollheim C.B. Regulation of cytosolic calcium and insulin secretion by galanin and ATP receptors: interactions of pertussis-toxin-sensitive and -insensitive signalling pathways. Biochem J 1994, 303(Pt 3):885-891.
24. Corbett J.A., McDaniel M.L. Does nitric oxide mediate autoimmune destruction of beta-cells? Possible therapeutic interventions in IDDM. Diabetes 1992, 41:897-903.
25. Thomas H.E., Darwiche R., Corbett J.A., Kay T.W. Interleukin-1 plus gamma-interferon-induced pancreatic beta-cell dysfunction is mediated by beta-cell nitric oxide production. Diabetes 2002, 51:311-316.
26. Bredt D.S., Snyder S.H. Nitric oxide: a physiologic messenger molecule. Annu Rev Biochem 1994, 63:175-195.
27. Delaney C.A., Tyrberg B., Bouwens L., Vaghef H., Hellman B., Eizirik D.L. Sensitivity of human pancreatic islets to peroxynitrite-induced cell dysfunction and death. FEBS Lett 1996, 394:300-306.
28. Kostraba J.N., Gay E.C., Rewers M., Hamman R.F. Nitrate levels in community drinking waters and risk of IDDM. An ecological analysis. Diabetes Care 1992, 15:1505-1508.
29. Virtanen S.M., Jaakkola L., Rasanen L., Ylonen K., Aro A., Lounamaa R., et al. Nitrate and nitrite intake and the risk for type 1 diabetes in Finnish children. Childhood Diabetes in Finland Study Group. Diabet Med 1994, 11:656-662.
30. Lenzen S., Drinkgern J., Tiedge M. Low antioxidant enzyme gene expression in pancreatic islets compared with various other mouse tissues. Free Radic Biol Med 1996, 20:463-466.
31. Tiedge M., Lortz S., Drinkgern J., Lenzen S. Relation between antioxidant enzyme gene expression and antioxidative defense status of insulin-producing cells. Diabetes 1997, 46:1733-1742.
32. Messmer U.K., Brune B. Modulation of inducible nitric oxide synthase in RINm5F cells. Cell Signal 1994, 6:17-24.
33. Kwon G., Corbett J.A., Rodi C.P., Sullivan P., McDaniel M.L. Interleukin-1 beta-induced nitric oxide synthase expression by rat pancreatic beta-cells: evidence for the involvement of nuclear factor kappa B in the signaling mechanism. Endocrinology 1995, 136:4790-4795.
34. Larsen C.M., Wadt K.A., Juhl L.F., Andersen H.U., Karlsen A.E., Su M.S., et al. Interleukin-1beta-induced rat pancreatic islet nitric oxide synthesis requires both the p38 and extracellular signal-regulated kinase 1/2 mitogen-activated protein kinases. J Biol Chem 1998, 273:15294-15300.
35. Kim M.J., Ryu G.R., Chung J.S., Sim S.S., Min D.S., Rhie D.J., et al. Protective effects of epicatechin against the toxic effects of streptozotocin on rat pancreatic islets: in vivo and in vitro. Pancreas 2003, 26:292-299.
36. O'Leary K.A., Day A.J., Needs P.W., Sly W.S., O'Brien N.M., Williamson G. Flavonoid glucuronides are substrates for human liver beta-glucuronidase. FEBS Lett 2001, 503:103-106.
37. Nemeth K., Plumb G.W., Berrin J.G., Juge N., Jacob R., Naim H.Y., et al. Deglycosylation by small intestinal epithelial cell beta-glucosidases is a critical step in the absorption and metabolism of dietary flavonoid glycosides in humans. Eur J Nutr 2003, 42:29-42.
38. Mullen W., Edwards C.A., Crozier A. Absorption, excretion and metabolite profiling of methyl-, glucuronyl-, glucosyl- and sulpho-conjugates of quercetin in human plasma and urine after ingestion of onions. Br J Nutr 2006, 96:107-116.
39. Kroon P.A., Clifford M.N., Crozier A., Day A.J., Donovan J.L., Manach C., et al. How should we assess the effects of exposure to dietary polyphenols in vitro?. Am J Clin Nutr 2004, 80:15-21.
40. Pudil R., Pidrman V., Krejsek J., Gregor J., Tichy M., Andrys C., et al. Cytokines and adhesion molecules in the course of acute myocardial infarction. Clin Chim Acta 1999, 280:127-134.
41. Misaki Y., Miyauchi R., Mochizuki K., Takabe S., Shimada M., Ichikawa Y., et al. Plasma interleukin-1beta concentrations are closely associated with fasting blood glucose levels in healthy and preclinical middle-aged nonoverweight and overweight Japanese men. Metabolism 2010, 59:1465-1471.
42. Wadt K.A., Larsen C.M., Andersen H.U., Nielsen K., Karlsen A.E., Mandrup-Poulsen T. Ciliary neurotrophic factor potentiates the beta-cell inhibitory effect of IL-1beta in rat pancreatic islets associated with increased nitric oxide synthesis and increased expression of inducible nitric oxide synthase. Diabetes 1998, 47:1602-1608.
43. Arafat H.A., Katakam A.K., Chipitsyna G., Gong Q., Vancha A.R., Gabbeta J., et al. Osteopontin protects the islets and beta-cells from interleukin-1 beta-mediated cytotoxicity through negative feedback regulation of nitric oxide. Endocrinology 2007, 148:575-584.
44. Kleinert H., Pautz A., Linker K., Schwarz P.M. Regulation of the expression of inducible nitric oxide synthase. Eur J Pharmacol 2004, 500:255-266.
45. Xie Q.W., Kashiwabara Y., Nathan C. Role of transcription factor NF-kappa B/Rel in induction of nitric oxide synthase. J Biol Chem 1994, 269:4705-4708.
46. Karin M. How NF-kappaB is activated: the role of the IkappaB kinase (IKK) complex. Oncogene 1999, 18:6867-6874.
47. Sandler S., Eizirik D.L., Svensson C., Strandell E., Welsh M., Welsh N. Biochemical and molecular actions of interleukin-1 on pancreatic beta-cells. Autoimmunity 1991, 10:241-253.
48. Corbett J.A., Wang J.L., Hughes J.H., Wolf B.A., Sweetland M.A., Lancaster J.R., et al. Nitric oxide and cyclic GMP formation induced by interleukin 1 beta in islets of Langerhans. Evidence for an effector role of nitric oxide in islet dysfunction. Biochem J 1992, 287(Pt 1):229-235.
49. Winterbone M.S., Tribolo S., Needs P.W., Kroon P.A., Hughes D.A. Physiologically relevant metabolites of quercetin have no effect on adhesion molecule or chemokine expression in human vascular smooth muscle cells. Atherosclerosis 2009, 202:431-438.
50. O'Leary K.A., de Pascual-Tereasa S., Needs P.W., Bao Y.P., O'Brien N.M., Williamson G. Effect of flavonoids and vitamin E on cyclooxygenase-2 (COX-2) transcription. Mutat Res 2004, 551:245-254.
51. Suri S., Taylor M.A., Verity A., Tribolo S., Needs P.W., Kroon P.A., et al. A comparative study of the effects of quercetin and its glucuronide and sulfate metabolites on human neutrophil function in vitro. Biochem Pharmacol 2008, 76:645-653.
52. Williamson G., Day A.J., Plumb G.W., Couteau D. Human metabolic pathways of dietary flavonoids and cinnamates. Biochem Soc Trans 2000, 28:16-22.